ClinicalTrials.Veeva

Menu

Interest of EMDR Schizophrenic Disorders (EMDRpsychose)

H

Hôpital NOVO

Status

Terminated

Conditions

Schizophrenic Disorders

Treatments

Other: EMDR group
Other: Control group

Study type

Observational

Funder types

Other

Identifiers

NCT05164289
CHRD 1721

Details and patient eligibility

About

The purpose of this study is to determine the interest of the use of EMDR (Eye Movement Desensitization and Reprocessing) psychotherapy in the management of psychotic disorders, in particular schizophrenic disorders.

Full description

Since 2015 more and more studies conducted by researchers, especially Dutch and English, are interested in the use of EMDR (Eye Movement Desensitization and Reprocessing) for other pathologies such as bipolar disorder, unipolar depression, anxiety disorders, psychotic disorders, substance use disorders and chronic pain.

These studies show that EMDR appears to be a technique that is both effective, capable of significantly improving symptoms, and without risk for patients, while respecting the protocol and the clinical stabilization provided during the procedure.

To date, the use of EMDR for the management of psychotic patients has not been the subject of any prospective study in France and the authors' conclusions converge on the fact that it is essential to carry out more research on the subject.

For this, the investigators wish to evaluate the effect of EMDR on the management of patients with schizophrenic disorders, on the basis that this psychotherapy would improve their quality of life (improvement of all the specific scores used in psychiatry). : PANSS, DES, HAD and WEMWBS scales).

Finally, the investigators believe that it is relevant to assess the benefit of EMDR six months after hospitalization of patients, in order to measure the maintenance of this efficacy in the medium term

Enrollment

6 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥ 18 years and over,
  • Hospitalized for decompensated psychotic disorder, Positive diagnosis of schizophrenia or schizoaffective disorder (according to the DSM-V psychiatry manual),
  • With positive or negative symptoms according to the Positive and Negative Syndrome Scale (PANSS),
  • Stabilized clinical condition (considered compatible with hospital discharge),
  • With ambulatory follow-up planned after hospitalization

Exclusion criteria

  • < 18 years,
  • Patients who do not meet the diagnostic criteria (according to the DSM-V psychiatry manual) for schizophrenic or schizoaffective disorder),
  • Non-French speaking or illiterate patients,
  • Cognitive disorders making it impossible the understanding and the none- opposition to the study,
  • Non-stabilized clinical condition (incompatible with hospital discharge),

Trial design

6 participants in 2 patient groups

Control group
Description:
Patients in the control group will have simple consultations on D15, D30, D45, D60 and D75
Treatment:
Other: Control group
EMDR group
Description:
Patients in the EMDR group will have EMDR session on D15, D30, D45, D60 and D75
Treatment:
Other: EMDR group

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems